Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.24.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Apr. 30, 2022 $ 8,350 $ 81,555,379 $ (58,336,414) $ 23,227,315
Beginning balance, shares at Apr. 30, 2022 8,349,843      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 184,531 184,531
Net loss (1,945,358) (1,945,358)
Ending balance, value at Jul. 31, 2022 $ 8,350 81,747,312 (60,281,772) 21,473,890
Ending balance, shares at Jul. 31, 2022 8,349,843      
Beginning balance, value at Apr. 30, 2022 $ 8,350 81,555,379 (58,336,414) 23,227,315
Beginning balance, shares at Apr. 30, 2022 8,349,843      
Net loss       (5,735,688)
Ending balance, value at Jan. 31, 2023 $ 8,372 82,652,057 (64,072,102) 18,588,327
Ending balance, shares at Jan. 31, 2023 8,371,590      
Beginning balance, value at Jul. 31, 2022 $ 8,350 81,747,312 (60,281,772) 21,473,890
Beginning balance, shares at Jul. 31, 2022 8,349,843      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 184,532 184,532
Net loss (1,896,572) (1,896,572)
Ending balance, value at Oct. 31, 2022 $ 8,350 81,939,246 (62,178,344) 19,769,252
Ending balance, shares at Oct. 31, 2022 8,349,843      
Accretion of stock based compensation in connection with stock option grants 470,802 470,802
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 184,531 184,531
Net loss (1,893,758) (1,893,758)
Issuance of common stock for services $ 13 52,487 52,500
Issuance of common stock for services, shares 12,935      
Issuance of common stock for accrued services $ 1 4,999 $ 5,000
Issuance of common stock for accrued services, shares       885
Issuance of common stock for vested restricted stock unit 8 (8)
Issuance of common stock for vested restricted stock unit, shares       7,927
Ending balance, value at Jan. 31, 2023 $ 8,372 82,652,057 (64,072,102) $ 18,588,327
Ending balance, shares at Jan. 31, 2023 8,371,590      
Beginning balance, value at Apr. 30, 2023 $ 9,296 84,799,263 (65,950,618) 18,857,941
Beginning balance, shares at Apr. 30, 2023 9,295,837      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 184,531 184,531
Net loss (2,894,683) (2,894,683)
Ending balance, value at Jul. 31, 2023 $ 9,296 84,991,196 (68,845,301) 16,155,191
Ending balance, shares at Jul. 31, 2023 9,295,837      
Beginning balance, value at Apr. 30, 2023 $ 9,296 84,799,263 (65,950,618) 18,857,941
Beginning balance, shares at Apr. 30, 2023 9,295,837      
Net loss       (4,838,767)
Ending balance, value at Jan. 31, 2024 $ 9,332 85,454,756 (70,789,385) 14,674,703
Ending balance, shares at Jan. 31, 2024 9,332,277      
Beginning balance, value at Jul. 31, 2023 $ 9,296 84,991,196 (68,845,301) 16,155,191
Beginning balance, shares at Jul. 31, 2023 9,295,837      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 184,531 184,531
Net loss (258,430) (258,430)
Issuance of common stock for services $ 13 52,487 52,500
Issuance of common stock for services, shares 13,147      
Issuance of common stock for prepaid services $ 25 143,975 144,000
Issuance of common stock for prepaid services, shares 25,000      
Cancellation of shares $ (2) 2
Cancellation of shares, shares (1,707)      
Ending balance, value at Oct. 31, 2023 $ 9,332 85,379,593 (69,103,731) 16,285,194
Ending balance, shares at Oct. 31, 2023 9,332,277      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 67,761 67,761
Net loss (1,685,654) (1,685,654)
Ending balance, value at Jan. 31, 2024 $ 9,332 $ 85,454,756 $ (70,789,385) $ 14,674,703
Ending balance, shares at Jan. 31, 2024 9,332,277